Company / Net Debt per Share
Integra Lifesciences Holdings Net Debt per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$6.12
FY2025
5-year range
$3.74 / $6.16
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
#49 of 98
Health Care
What the data says
At $6.12, Integra Lifesciences Holdings's net debt per share ranks #50 of 98 in the Health Care sector. Increased from $5.83 to $6.12 over the past 2 years.
Based on SEC 10-K filings.
6.12 in FY2025 with a 5-year CAGR of +4.8%.
Increased from $5.83 to $6.12 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +4.8%
- 10-Year CAGR
- -
Sector benchmark
#50 of 98 in Health CareTop 50% of 98This company $6.12 Sector average $7.39
▼
-17.2% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 0.6% year-over-year.
- Ranks #49 out of 98 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2018.
- Lowest net debt per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.12 | -0.6% |
| FY2024 | $6.16 | +5.5% |
| FY2023 | $5.83 | +56.2% |
| FY2022 | $3.74 | -2.2% |
| FY2021 | $3.82 | -21.3% |
| FY2020 | $4.85 | -43.5% |
| FY2019 | $8.58 | -10.8% |
| FY2018 | $9.61 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026